IL1R2 and gram-positive bacterial infections: Another highly upregulated gene in the LPS treatment group (IL1R2), was recently proposed as a biomarker for differentiating gram-negative and gram-positive bacterial infections in mice, as this gene was expressed at a higher level in mice challenged with inactive gram-negative bacteria (Escherichia coli) than inactive gram-positive bacteria (S. aureus)47.